These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 24704391)
1. A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives. Lamberti M; Porto S; Zappavigna S; Addeo E; Marra M; Miraglia N; Sannolo N; Vanacore D; Stiuso P; Caraglia M Toxicol Lett; 2014 Jun; 227(3):151-6. PubMed ID: 24704391 [TBL] [Abstract][Full Text] [Related]
2. 5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. Lamberti M; Porto S; Marra M; Zappavigna S; Grimaldi A; Feola D; Pesce D; Naviglio S; Spina A; Sannolo N; Caraglia M J Exp Clin Cancer Res; 2012 Jul; 31(1):60. PubMed ID: 22812382 [TBL] [Abstract][Full Text] [Related]
3. Levofolene modulates apoptosis induced by 5-fluorouracil through autophagy inhibition: clinical and occupational implications. Lamberti M; Porto S; Zappavigna S; Stiuso P; Tirino V; Desiderio V; Mele L; Caraglia M Int J Oncol; 2015 May; 46(5):1893-900. PubMed ID: 25709090 [TBL] [Abstract][Full Text] [Related]
4. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways. Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation in vitro of the cardiotoxic effects of 5-fluorouracil for the prevention of cardiovascular damage in health workers occupationally exposed]. Lamberti M; Caraglia M; Zappavigna S; Marra M; Ritonnaro C; Coppola MA; Naviglio S; Porto S; Marsella L; Sannolo N G Ital Med Lav Ergon; 2011; 33(3 Suppl):298-302. PubMed ID: 23393861 [TBL] [Abstract][Full Text] [Related]
7. A comparison of cardiomyocyte cytotoxic mechanisms for 5-fluorouracil and its pro-drug capecitabine. Eskandari MR; Moghaddam F; Shahraki J; Pourahmad J Xenobiotica; 2015 Jan; 45(1):79-87. PubMed ID: 25034007 [TBL] [Abstract][Full Text] [Related]
8. Dual effects of folinic acid in 5-fluorouracil induced killing of human tumor cell lines in vitro. Blomgren H; Edler D; Hallström M; Ragnhammar P Anticancer Res; 1996; 16(5A):2713-7. PubMed ID: 8917376 [TBL] [Abstract][Full Text] [Related]
9. Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress. Li W; Xu B; Xu J; Wu XL Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):192-7. PubMed ID: 19143757 [TBL] [Abstract][Full Text] [Related]
10. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines. Bjelogrlić SK; Srdić T; Radulović S J BUON; 2007; 12(1):71-6. PubMed ID: 17436405 [TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of 5-fluorouracil on HT-1080 human fibrosarcoma cells in vitro]. Liu HW; Niu XH; Xu HR; Zhang Q; Ding Y; Wang Q Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):889-93. PubMed ID: 23336373 [TBL] [Abstract][Full Text] [Related]
12. Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells. Pereira-Oliveira M; Reis-Mendes A; Carvalho F; Remião F; Bastos ML; Costa VM Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30634681 [TBL] [Abstract][Full Text] [Related]
13. 5-fluorouracil induced cardiotoxicity in albino rats. Kumar S; Gupta RK; Samal N Mater Med Pol; 1995; 27(2):63-6. PubMed ID: 8935192 [TBL] [Abstract][Full Text] [Related]
14. Cardioprotective activity of standardized extract of Ficus racemosa stem bark against doxorubicin-induced toxicity. Ahmed F; Urooj A Pharm Biol; 2012 Apr; 50(4):468-73. PubMed ID: 22136326 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress. Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523 [TBL] [Abstract][Full Text] [Related]
17. A study of various strategies to enhance the cytotoxic activity of 5-fluorouracil/leucovorin in human colorectal cancer cell lines. Scheithauer W; Temsch EM Anticancer Res; 1989; 9(6):1793-8. PubMed ID: 2627128 [TBL] [Abstract][Full Text] [Related]
18. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity. Shaib W; Lee V; Saif MW In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118 [TBL] [Abstract][Full Text] [Related]
19. Protective effect of thymoquinone nanoemulsion in reducing the cardiotoxic effect of 5-fluorouracil in rats. Karim B; Arabameri M; Alimoradi F; Mansoori R; Moghadamnia AA; Kazemi S; Hosseini SM Drug Dev Res; 2024 Apr; 85(2):e22171. PubMed ID: 38459752 [TBL] [Abstract][Full Text] [Related]
20. Alternative treatment options in colorectal cancer patients with 5-fluorouracil- or capecitabine-induced cardiotoxicity. Deboever G; Hiltrop N; Cool M; Lambrecht G Clin Colorectal Cancer; 2013 Mar; 12(1):8-14. PubMed ID: 23102544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]